| Changes in health and disease of the metalloprotease that cleaves von Willebrand factor PM Mannucci, MT Canciani, I Forza, F Lussana, A Lattuada, E Rossi Blood, The Journal of the American Society of Hematology 98 (9), 2730-2735, 2001 | 585 | 2001 |
| Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH M Cattaneo, C Cerletti, P Harrison, CPM Hayward, D Kenny, D Nugent, ... Journal of Thrombosis and Haemostasis 11 (6), 1183-1189, 2013 | 539 | 2013 |
| At the epicenter of the Covid-19 pandemic and humanitarian crises in Italy: changing perspectives on preparation and mitigation M Nacoti, A Ciocca, A Giupponi, P Brambillasca, F Lussana, M Pisano, ... NEJM Catalyst innovations in care delivery 1 (2), 2020 | 491 | 2020 |
| Comparison between different D‐D imer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study G Palareti, C Legnani, B Cosmi, E Antonucci, N Erba, D Poli, S Testa, ... International Journal of Laboratory Hematology 38 (1), 42-49, 2016 | 403 | 2016 |
| Prenatal exposure to the Dutch famine is associated with a preference for fatty foods and a more atherogenic lipid profile F Lussana, RC Painter, MC Ocke, HR Buller, PM Bossuyt, TJ Roseboom The American journal of clinical nutrition 88 (6), 1648-1652, 2008 | 278 | 2008 |
| Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review F Lussana, S Caberlon, C Pagani, PW Kamphuisen, HR Büller, ... Thrombosis research 124 (4), 409-417, 2009 | 244 | 2009 |
| Ruxolitinib‐associated infections: a systematic review and meta‐analysis F Lussana, M Cattaneo, A Rambaldi, A Squizzato American journal of hematology 93 (3), 339-347, 2018 | 169 | 2018 |
| Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count M Cattaneo, A Lecchi, ML Zighetti, F Lussana haematologica 92 (5), 694-697, 2007 | 160 | 2007 |
| Inflammation and myeloproliferative neoplasms F Lussana, A Rambaldi Journal of autoimmunity 85, 58-63, 2017 | 129 | 2017 |
| Usefulness of PFA‐100® testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time GM Podda, P Bucciarelli, F Lussana, A Lecchi, M Cattaneo Journal of Thrombosis and Haemostasis 5 (12), 2393-2398, 2007 | 117 | 2007 |
| Sleeping Beauty–engineered CAR T cells achieve antileukemic activity without severe toxicities CF Magnani, G Gaipa, F Lussana, D Belotti, G Gritti, S Napolitano, ... The Journal of clinical investigation 130 (11), 6021-6033, 2020 | 108 | 2020 |
| Blood levels of homocysteine, folate, vitamin B6 and B12 in women using oral contraceptives compared to non-users F Lussana, ML Zighetti, P Bucciarelli, M Cugno, M Cattaneo Thrombosis research 112 (1-2), 37-41, 2003 | 105 | 2003 |
| Pregnancy-related venous thromboembolism: risk and the effect of thromboprophylaxis F Lussana, M Coppens, M Cattaneo, S Middeldorp Thrombosis research 129 (6), 673-680, 2012 | 91 | 2012 |
| Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a … F Lussana, A Rambaldi, MC Finazzi, A van Biezen, M Scholten, E Oldani, ... haematologica 99 (5), 916, 2014 | 88 | 2014 |
| Achieving molecular remission before allogeneic stem cell transplantation in adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia: impact on … F Lussana, T Intermesoli, F Gianni, C Boschini, A Masciulli, O Spinelli, ... Biology of Blood and Marrow Transplantation 22 (11), 1983-1987, 2016 | 84 | 2016 |
| New approaches for measuring coagulation TW Barrowcliffe, M Cattaneo, GM Podda, P Bucciarelli, F Lussana, ... Haemophilia 12, 76-81, 2006 | 66 | 2006 |
| Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia N Maugeri, S Malato, EA Femia, M Pugliano, L Campana, F Lunghi, ... Blood, The Journal of the American Society of Hematology 118 (12), 3359-3366, 2011 | 63 | 2011 |
| Pregnancy complications predict thrombotic events in young women with essential thrombocythemia ML Randi, I Bertozzi, E Rumi, C Elena, G Finazzi, N Vianelli, N Polverelli, ... American journal of hematology 89 (3), 306-309, 2014 | 61 | 2014 |
| Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) F Lussana, F Dentali, R Abbate, E d'Aloja, A D'Angelo, V De Stefano, ... Thrombosis Research 124 (5), e19-e25, 2009 | 61 | 2009 |
| Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera F Lussana, A Carobbio, S Salmoiraghi, P Guglielmelli, AM Vannucchi, ... Journal of Hematology & Oncology 10, 1-8, 2017 | 56 | 2017 |
